NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
NewcelX Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026
$2.63+0.13 (+5.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 1.2
- Dividend yield
- –
Dividends
NewcelX has not reported a dividend
No dividend per share appears in NewcelX's annual filings since fiscal 2017.